CRA was retained to assess claims of misleading “all-natural” beverage product claims. In particular, CRA provided assessments of methods to determine alleged affects on pricing and sales apart from brand value and other information conveyed in the product’s label. In particular, CRA demonstrated that the introduction of such labels had no bearing on manufacturer pricing and was not associated with a price premium relative to other similar consumer products.
Life Sciences Litigation Insights: March 2022
Carl Washington et al. v. CVS Pharmacy Inc., Northern District of California, No. 4:15-vc-19-03504 On June 23, 2021 a federal jury in northern California...